Efficacy of omalizumab in delayed pressure urticaria: a case report

被引：63

作者：

Bindslev-Jensen, C. ^{[1
]}

Skov, P. S.

机构：

[1] Odense Univ Hosp, Dept Dermatol, DK-5000 Odense C, Denmark

来源：

ALLERGY | 2010年 / 65卷 / 01期

关键词：

asthma; basic immunology; basophil; dendritic cells; dermatology; drug allergy; food allergy; pharmacology; urticaria;

D O I：

10.1111/j.1398-9995.2009.02188.x

中图分类号：

R392 [医学免疫学];

学科分类号：

100102 ;

摘要：

引用

页码：138 / 139

页数：2

共 3 条

[1] Treatment of chronic autoimmune urticaria with omalizumab [J].

Kaplan, Allen P. ;

Joseph, Kusumam ;

Maykut, Robert J. ;

Geba, Gregory P. ;

Zeldin, Robert K. .

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2008, 122 (03) :569-573

[2] Validation of basophil histamine release against the autologous serum skin test and outcome of serum-induced basophil histamine release studies in a large population of chronic urticaria patients [J].

Platzer, MH ;

Grattan, CEH ;

Poulsen, LK ;

Skov, PS .

ALLERGY, 2005, 60 (09) :1152-1156

[3] EAACI/GA2LEN/EDF guideline:: management of urticaria [J].

Zuberbier, T ;

Bindslev-Jensen, C ;

Canonica, W ;

Grattan, CEH ;

Greaves, MW ;

Henz, BM ;

Kapp, A ;

Kozel, MMA ;

Maurer, M ;

Merk, HF ;

Schäfer, T ;

Simon, D ;

Vena, GA ;

Wedi, B .

ALLERGY, 2006, 61 (03) :321-331

← 1 →